English

Accelerate Diagnostics, Inc.

EDGAR

AXDX Annual report amendment (10-K/A) · filed 2025-04-30

Annual consolidated revenue for 2024: about USD 11.7M, using the latest reported figures. The previous period, 2023, was about USD 12.06M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

2.82 million USD

2024 Q4 · USD

Exact inputs and evidence

Revenue: 11698000 USD Source
Revenue: 8882000 USD Source

Operating margin

-281.68%

2024 Q4 · %

Exact inputs and evidence

Operating Income: -35310000 USD Source
Operating Income: -27378000 USD Source
Revenue: 11698000 USD Source
Revenue: 8882000 USD Source

Operating cash flow

-5.1 million USD

2024 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -24200000 USD Source
Operating Cash Flow: -19100000 USD Source

Cash and cash equivalents: 15.1 million USD 2024-12-31 Source
Exact value

15098000 USD
Long-term debt including current maturities: 80 thousand USD 2022-09-30 Source
Exact value

80000 USD
Shares outstanding: 25.2 million shares 2024-12-31 Source
Exact value

25186582 shares

Reported share-count change

72.87% · 10.6 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

14569500 shares · 2023-12-31· Source
25186582 shares · 2024-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

11.7 million USD

2024-01-01 – 2024-12-31

Exact inputs and evidence

Revenue: 2921000 USD · 2024-01-01 – 2024-03-31 Source
Revenue: 2986000 USD · 2024-04-01 – 2024-06-30 Source
Revenue: 2975000 USD · 2024-07-01 – 2024-09-30 Source
Revenue: 11698000 USD · 2024-01-01 – 2024-12-31 Source
Revenue: 8882000 USD · 2024-01-01 – 2024-09-30 Source

Net income

-49.9 million USD

2024-01-01 – 2024-12-31

Exact inputs and evidence

Net income: -14200000 USD · 2024-01-01 – 2024-03-31 Source
Net income: -11588000 USD · 2024-04-01 – 2024-06-30 Source
Net income: -14639000 USD · 2024-07-01 – 2024-09-30 Source
Net income: -50000000 USD · 2024-01-01 – 2024-12-31 Source
Net income: -40500000 USD · 2024-01-01 – 2024-09-30 Source

Operating cash flow

-24.2 million USD

2024-01-01 – 2024-12-31

Exact inputs and evidence

Operating cash flow: -8500000 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: -16000000 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -8500000 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: -19100000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -16000000 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -24200000 USD · 2024-01-01 – 2024-12-31 Source
Operating cash flow: -19100000 USD · 2024-01-01 – 2024-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2025-04-30.

Financial data available through: 2024-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2024-12-31
Operating income: 11 of 11 periods available· newest 2024-12-31
Net income: 11 of 11 periods available· newest 2024-12-31
Operating cash flow: 11 of 11 periods available· newest 2024-12-31
capital expenditure: No compatible figures in this window
Total assets: 11 of 11 periods available· newest 2024-12-31
Total liabilities: 11 of 11 periods available· newest 2024-12-31
Current assets: 11 of 11 periods available· newest 2024-12-31
Current liabilities: 11 of 11 periods available· newest 2024-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2024-12-31
Long-term debt including current maturities: 3 of 11 periods available· newest 2021-12-31
Shares outstanding: 11 of 11 periods available· newest 2024-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-3%

Prior period

USD 12.06 million

2023-01-01 – 2023-12-31
Current period

USD 11.7 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

11698000 − 12059000 = -361000 USD

12059000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
11698000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Accelerate Diagnostics, Inc. · 2024-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Year-over-year change in Revenue: -361000 USD Concept: fundies:Revenue Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 11698000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828025014205/axdx-20241231.htm#1844815 Filing: 000162828025014205 Input fundies:Revenue: 12059000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828025014205/axdx-20241231.htm#1845725 Filing: 000162828025014205
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 11.62 million

Prior period

−USD 61.62 million

2023-01-01 – 2023-12-31
Current period

−USD 50 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-50000000 − -61618000 = 11618000 USD

-61618000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-50000000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Accelerate Diagnostics, Inc. · 2024-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Year-over-year change in Net income: 11618000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -50000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828025014205/axdx-20241231.htm#1158925 Filing: 000162828025014205 Input fundies:NetIncome: -61618000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828025014205/axdx-20241231.htm#1070643 Filing: 000162828025014205
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 16 million

Prior period

−USD 40.2 million

2023-01-01 – 2023-12-31
Current period

−USD 24.2 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-24200000 − -40196000 = 15996000 USD

-40196000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-24200000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Accelerate Diagnostics, Inc. · 2024-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Year-over-year change in Operating cash flow: 15996000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -24200000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828025014205/axdx-20241231.htm#1159119 Filing: 000162828025014205 Input fundies:OperatingCashFlow: -40196000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828025014205/axdx-20241231.htm#1101307 Filing: 000162828025014205
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2024-01-01 – 2024-12-31

Revenue USD 11.7 million 100% of revenue
Cost of revenue USD 8.99 million 77% of revenue
Operating expenses USD 38.01 million 325% of revenue
Operating income −USD 35.31 million −302% of revenue
Tax, interest and other Derived USD 14.69 million 126% of revenue
Net income −USD 50 million −427% of revenue

Cash

Operating cash flow −USD 24.2 million −207% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 Operating loss: operating costs were 31,086% of revenue.
2016 Operating loss: operating costs were 27,133% of revenue.
2017 Operating loss: operating costs were 1,637% of revenue.
2018 Operating loss: operating costs were 1,517% of revenue.
2019 Operating loss: operating costs were 883% of revenue.
2020 Operating loss: operating costs were 671% of revenue.
2021 Operating loss: operating costs were 707% of revenue.
2022 Operating loss: operating costs were 593% of revenue.
2023 Operating loss: operating costs were 548% of revenue.
2024 Operating loss: operating costs were 402% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	147000	45696000 Derived	-45549000	-51000 Derived	-45498000	Unavailable	Source 2015-01-01 – 2015-12-31: 147000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -45549000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -45498000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -35126000 USD Inspect Operating Cash Flow Open source
2016 2016-01-01 – 2016-12-31	246000	66747000 Derived	-66501000	-127000 Derived	-66374000	Unavailable	Source 2016-01-01 – 2016-12-31: 246000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -66501000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -66374000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -53408000 USD Inspect Operating Cash Flow Open source
2017 2017-01-01 – 2017-12-31	4177000	68361000 Derived	-64184000	-156000 Derived	-64028000	Unavailable	Source 2017-01-01 – 2017-12-31: 4177000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -64184000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -64028000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -55746000 USD Inspect Operating Cash Flow Open source
2018 2018-01-01 – 2018-12-31	5670000	86039000 Derived	-80369000	7957000 Derived	-88326000	Unavailable	Source 2018-01-01 – 2018-12-31: 5670000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -80369000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -88326000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -67756000 USD Inspect Operating Cash Flow Open source
2019 2019-01-01 – 2019-12-31	9297000	82128000 Derived	-72831000	11474000 Derived	-84305000	Unavailable	Source 2019-01-01 – 2019-12-31: 9297000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -72831000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -84305000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -64794000 USD Inspect Operating Cash Flow Open source
2020 2020-01-01 – 2020-12-31	11165000	74865000 Derived	-63700000	14508000 Derived	-78208000	Unavailable	Source 2020-01-01 – 2020-12-31: 11165000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -63700000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -78208000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -50394000 USD Inspect Operating Cash Flow Open source
2021 2021-01-01 – 2021-12-31	11782000	83342000 Derived	-71560000	6142000 Derived	-77702000	Unavailable	Source 2021-01-01 – 2021-12-31: 11782000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -71560000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -77702000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -47323000 USD Inspect Operating Cash Flow Open source
2022 2022-01-01 – 2022-12-31	12752000	75557000 Derived	-62805000	-312000 Derived	-62493000	Unavailable	Source 2022-01-01 – 2022-12-31: 12752000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -62805000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -62493000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -48728000 USD Inspect Operating Cash Flow Open source
2023 2023-01-01 – 2023-12-31	12059000	66087000 Derived	-54028000	7590000 Derived	-61618000	Unavailable	Source 2023-01-01 – 2023-12-31: 12059000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -54028000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -61618000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -40196000 USD Inspect Operating Cash Flow Open source
2024 2024-01-01 – 2024-12-31	11698000	47008000 Derived	-35310000	14690000 Derived	-50000000	Unavailable	Source 2024-01-01 – 2024-12-31: 11698000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -35310000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -50000000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -24200000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 11.7M 2024

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	147000	Revenue: 147000 Open source
20162016-12-31	Revenue	246000	Revenue: 246000 Open source
20172017-12-31	Revenue	4177000	Revenue: 4177000 Open source
20182018-12-31	Revenue	5670000	Revenue: 5670000 Open source
20192019-12-31	Revenue	9297000	Revenue: 9297000 Open source
20202020-12-31	Revenue	11165000	Revenue: 11165000 Open source
20212021-12-31	Revenue	11782000	Revenue: 11782000 Open source
20222022-12-31	Revenue	12752000	Revenue: 12752000 Open source
20232023-12-31	Revenue	12059000	Revenue: 12059000 Open source
20242024-12-31	Revenue	11698000	Revenue: 11698000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-3% 2024

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	20.5%	Revenue: 147000 Open source Revenue: 122000 Open source
20162016-12-31	Year over year	67.3%	Revenue: 246000 Open source Revenue: 147000 Open source
20172017-12-31	Year over year	1,598%	Revenue: 4177000 Open source Revenue: 246000 Open source
20182018-12-31	Year over year	35.7%	Revenue: 5670000 Open source Revenue: 4177000 Open source
20192019-12-31	Year over year	64%	Revenue: 9297000 Open source Revenue: 5670000 Open source
20202020-12-31	Year over year	20.1%	Revenue: 11165000 Open source Revenue: 9297000 Open source
20212021-12-31	Year over year	5.5%	Revenue: 11782000 Open source Revenue: 11165000 Open source
20222022-12-31	Year over year	8.2%	Revenue: 12752000 Open source Revenue: 11782000 Open source
20232023-12-31	Year over year	-5.4%	Revenue: 12059000 Open source Revenue: 12752000 Open source
20242024-12-31	Year over year	-3%	Revenue: 11698000 Open source Revenue: 12059000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -301.8% 2024

Net margin -427.4% 2024

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	-30,985.7%	Operating Income: -45549000 Open source Revenue: 147000 Open source
20162016-12-31	Operating margin	-27,032.9%	Operating Income: -66501000 Open source Revenue: 246000 Open source
20172017-12-31	Operating margin	-1,536.6%	Operating Income: -64184000 Open source Revenue: 4177000 Open source
20182018-12-31	Operating margin	-1,417.4%	Operating Income: -80369000 Open source Revenue: 5670000 Open source
20192019-12-31	Operating margin	-783.4%	Operating Income: -72831000 Open source Revenue: 9297000 Open source
20202020-12-31	Operating margin	-570.5%	Operating Income: -63700000 Open source Revenue: 11165000 Open source
20212021-12-31	Operating margin	-607.4%	Operating Income: -71560000 Open source Revenue: 11782000 Open source
20222022-12-31	Operating margin	-492.5%	Operating Income: -62805000 Open source Revenue: 12752000 Open source
20232023-12-31	Operating margin	-448%	Operating Income: -54028000 Open source Revenue: 12059000 Open source
20242024-12-31	Operating margin	-301.8%	Operating Income: -35310000 Open source Revenue: 11698000 Open source
20152015-12-31	Net margin	-30,951%	Net Income: -45498000 Open source Revenue: 147000 Open source
20162016-12-31	Net margin	-26,981.3%	Net Income: -66374000 Open source Revenue: 246000 Open source
20172017-12-31	Net margin	-1,532.9%	Net Income: -64028000 Open source Revenue: 4177000 Open source
20182018-12-31	Net margin	-1,557.8%	Net Income: -88326000 Open source Revenue: 5670000 Open source
20192019-12-31	Net margin	-906.8%	Net Income: -84305000 Open source Revenue: 9297000 Open source
20202020-12-31	Net margin	-700.5%	Net Income: -78208000 Open source Revenue: 11165000 Open source
20212021-12-31	Net margin	-659.5%	Net Income: -77702000 Open source Revenue: 11782000 Open source
20222022-12-31	Net margin	-490.1%	Net Income: -62493000 Open source Revenue: 12752000 Open source
20232023-12-31	Net margin	-511%	Net Income: -61618000 Open source Revenue: 12059000 Open source
20242024-12-31	Net margin	-427.4%	Net Income: -50000000 Open source Revenue: 11698000 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 147000 Open source Operating Cash Flow: -35126000 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 246000 Open source Operating Cash Flow: -53408000 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 4177000 Open source Operating Cash Flow: -55746000 Open source
20182018-12-31	Free cash flow margin	Not reported	Revenue: 5670000 Open source Operating Cash Flow: -67756000 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 9297000 Open source Operating Cash Flow: -64794000 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 11165000 Open source Operating Cash Flow: -50394000 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 11782000 Open source Operating Cash Flow: -47323000 Open source
20222022-12-31	Free cash flow margin	Not reported	Revenue: 12752000 Open source Operating Cash Flow: -48728000 Open source
20232023-12-31	Free cash flow margin	Not reported	Revenue: 12059000 Open source Operating Cash Flow: -40196000 Open source
20242024-12-31	Free cash flow margin	Not reported	Revenue: 11698000 Open source Operating Cash Flow: -24200000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -24.2M 2024

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	-35126000	Operating Cash Flow: -35126000 Open source
20162016-12-31	Operating cash flow	-53408000	Operating Cash Flow: -53408000 Open source
20172017-12-31	Operating cash flow	-55746000	Operating Cash Flow: -55746000 Open source
20182018-12-31	Operating cash flow	-67756000	Operating Cash Flow: -67756000 Open source
20192019-12-31	Operating cash flow	-64794000	Operating Cash Flow: -64794000 Open source
20202020-12-31	Operating cash flow	-50394000	Operating Cash Flow: -50394000 Open source
20212021-12-31	Operating cash flow	-47323000	Operating Cash Flow: -47323000 Open source
20222022-12-31	Operating cash flow	-48728000	Operating Cash Flow: -48728000 Open source
20232023-12-31	Operating cash flow	-40196000	Operating Cash Flow: -40196000 Open source
20242024-12-31	Operating cash flow	-24200000	Operating Cash Flow: -24200000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	Unavailable	Operating Cash Flow: -35126000 Open source
20162016-12-31	Free cash flow	Unavailable	Operating Cash Flow: -53408000 Open source
20172017-12-31	Free cash flow	Unavailable	Operating Cash Flow: -55746000 Open source
20182018-12-31	Free cash flow	Unavailable	Operating Cash Flow: -67756000 Open source
20192019-12-31	Free cash flow	Unavailable	Operating Cash Flow: -64794000 Open source
20202020-12-31	Free cash flow	Unavailable	Operating Cash Flow: -50394000 Open source
20212021-12-31	Free cash flow	Unavailable	Operating Cash Flow: -47323000 Open source
20222022-12-31	Free cash flow	Unavailable	Operating Cash Flow: -48728000 Open source
20232023-12-31	Free cash flow	Unavailable	Operating Cash Flow: -40196000 Open source
20242024-12-31	Free cash flow	Unavailable	Operating Cash Flow: -24200000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

296.2% 2024

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Liabilities / assets	4.5%	Total Liabilities: 6306000 Open source Total Assets: 139324000 Open source
20162016-12-31	Liabilities / assets	6.1%	Total Liabilities: 5036000 Open source Total Assets: 82852000 Open source
20172017-12-31	Liabilities / assets	5.4%	Total Liabilities: 6808000 Open source Total Assets: 125512000 Open source
20182018-12-31	Liabilities / assets	69%	Total Liabilities: 127890000 Open source Total Assets: 185265000 Open source
20192019-12-31	Liabilities / assets	105.5%	Total Liabilities: 141803000 Open source Total Assets: 134424000 Open source
20202020-12-31	Liabilities / assets	167.2%	Total Liabilities: 156237000 Open source Total Assets: 93425000 Open source
20212021-12-31	Liabilities / assets	142.2%	Total Liabilities: 118118000 Open source Total Assets: 83047000 Open source
20222022-12-31	Liabilities / assets	134.2%	Total Liabilities: 87279000 Open source Total Assets: 65015000 Open source
20232023-12-31	Liabilities / assets	163.4%	Total Liabilities: 51254000 Open source Total Assets: 31366000 Open source
20242024-12-31	Liabilities / assets	296.2%	Total Liabilities: 84596000 Open source Total Assets: 28556000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.71× 2024

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Current assets / current liabilities	25.28×	Current Assets: 134151000 Open source Current Liabilities: 5306000 Open source
20162016-12-31	Current assets / current liabilities	19.44×	Current Assets: 78448000 Open source Current Liabilities: 4036000 Open source
20172017-12-31	Current assets / current liabilities	17.75×	Current Assets: 120488000 Open source Current Liabilities: 6787000 Open source
20182018-12-31	Current assets / current liabilities	22.88×	Current Assets: 177640000 Open source Current Liabilities: 7763000 Open source
20192019-12-31	Current assets / current liabilities	14.93×	Current Assets: 121852000 Open source Current Liabilities: 8162000 Open source
20202020-12-31	Current assets / current liabilities	11.76×	Current Assets: 81987000 Open source Current Liabilities: 6969000 Open source
20212021-12-31	Current assets / current liabilities	10.56×	Current Assets: 73331000 Open source Current Liabilities: 6945000 Open source
20222022-12-31	Current assets / current liabilities	0.84×	Current Assets: 56014000 Open source Current Liabilities: 66557000 Open source
20232023-12-31	Current assets / current liabilities	2.03×	Current Assets: 24466000 Open source Current Liabilities: 12034000 Open source
20242024-12-31	Current assets / current liabilities	0.71×	Current Assets: 22238000 Open source Current Liabilities: 31201000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	−USD 45.5 million Exact value Exact value: -45498000 USD 2015-01-01 – 2015-12-31: -45498000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Accelerate Diagnostics, Inc. · 2015-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Net Income: -45498000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -45498000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828018002558/axdx-20171231.xml#259048 Filing: 000162828018002558 The citation records this snapshot. The page link may show a newer release later.	−USD 35.13 million Exact value Exact value: -35126000 USD 2015-01-01 – 2015-12-31: -35126000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Accelerate Diagnostics, Inc. · 2015-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Operating Cash Flow: -35126000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -35126000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828018002558/axdx-20171231.xml#258412 Filing: 000162828018002558 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2016-01-01 – 2016-12-31	−USD 66.37 million Exact value Exact value: -66374000 USD 2016-01-01 – 2016-12-31: -66374000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Accelerate Diagnostics, Inc. · 2016-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Net Income: -66374000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -66374000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828019002318/axdx-20181231.xml#348183 Filing: 000162828019002318 The citation records this snapshot. The page link may show a newer release later.	−USD 53.41 million Exact value Exact value: -53408000 USD 2016-01-01 – 2016-12-31: -53408000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Accelerate Diagnostics, Inc. · 2016-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Operating Cash Flow: -53408000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -53408000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828019002318/axdx-20181231.xml#347547 Filing: 000162828019002318 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	−USD 64.03 million Exact value Exact value: -64028000 USD 2017-01-01 – 2017-12-31: -64028000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Accelerate Diagnostics, Inc. · 2017-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Net Income: -64028000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -64028000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828020002502/axdx-123119x10k.htm#1189652 Filing: 000162828020002502 The citation records this snapshot. The page link may show a newer release later.	−USD 55.75 million Exact value Exact value: -55746000 USD 2017-01-01 – 2017-12-31: -55746000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Accelerate Diagnostics, Inc. · 2017-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Operating Cash Flow: -55746000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -55746000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828020002502/axdx-123119x10k.htm#1226049 Filing: 000162828020002502 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2018-01-01 – 2018-12-31	−USD 88.33 million Exact value Exact value: -88326000 USD 2018-01-01 – 2018-12-31: -88326000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Accelerate Diagnostics, Inc. · 2018-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Net Income: -88326000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -88326000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828021003678/axdx-20201231.htm#1051448 Filing: 000162828021003678 The citation records this snapshot. The page link may show a newer release later.	−USD 67.76 million Exact value Exact value: -67756000 USD 2018-01-01 – 2018-12-31: -67756000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Accelerate Diagnostics, Inc. · 2018-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Operating Cash Flow: -67756000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -67756000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828021003678/axdx-20201231.htm#1100079 Filing: 000162828021003678 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2019-01-01 – 2019-12-31	−USD 84.31 million Exact value Exact value: -84305000 USD 2019-01-01 – 2019-12-31: -84305000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Accelerate Diagnostics, Inc. · 2019-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Net Income: -84305000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -84305000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828022006049/axdx-20211231.htm#1202718 Filing: 000162828022006049 The citation records this snapshot. The page link may show a newer release later.	−USD 64.79 million Exact value Exact value: -64794000 USD 2019-01-01 – 2019-12-31: -64794000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Accelerate Diagnostics, Inc. · 2019-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Operating Cash Flow: -64794000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -64794000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828022006049/axdx-20211231.htm#1257570 Filing: 000162828022006049 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	−USD 78.21 million Exact value Exact value: -78208000 USD 2020-01-01 – 2020-12-31: -78208000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Accelerate Diagnostics, Inc. · 2020-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Net Income: -78208000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -78208000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828023010221/axdx-20221231.htm#1237636 Filing: 000162828023010221 The citation records this snapshot. The page link may show a newer release later.	−USD 50.39 million Exact value Exact value: -50394000 USD 2020-01-01 – 2020-12-31: -50394000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Accelerate Diagnostics, Inc. · 2020-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Operating Cash Flow: -50394000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -50394000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828023010221/axdx-20221231.htm#1280139 Filing: 000162828023010221 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−USD 77.7 million Exact value Exact value: -77702000 USD 2021-01-01 – 2021-12-31: -77702000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Accelerate Diagnostics, Inc. · 2021-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Net Income: -77702000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -77702000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828024013670/axdx-20231231.htm#1227110 Filing: 000162828024013670 The citation records this snapshot. The page link may show a newer release later.	−USD 47.32 million Exact value Exact value: -47323000 USD 2021-01-01 – 2021-12-31: -47323000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Accelerate Diagnostics, Inc. · 2021-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Operating Cash Flow: -47323000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -47323000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828024013670/axdx-20231231.htm#1271314 Filing: 000162828024013670 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2022-01-01 – 2022-12-31	−USD 62.49 million Exact value Exact value: -62493000 USD 2022-01-01 – 2022-12-31: -62493000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Accelerate Diagnostics, Inc. · 2022-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Net Income: -62493000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -62493000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828024013670/axdx-20231231.htm#1226413 Filing: 000162828024013670 The citation records this snapshot. The page link may show a newer release later.	−USD 48.73 million Exact value Exact value: -48728000 USD 2022-01-01 – 2022-12-31: -48728000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Accelerate Diagnostics, Inc. · 2022-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Operating Cash Flow: -48728000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -48728000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828024013670/axdx-20231231.htm#1270726 Filing: 000162828024013670 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2023 2023-01-01 – 2023-12-31	−USD 61.62 million Exact value Exact value: -61618000 USD 2023-01-01 – 2023-12-31: -61618000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Accelerate Diagnostics, Inc. · 2023-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Net Income: -61618000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -61618000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828025014205/axdx-20241231.htm#1070643 Filing: 000162828025014205 The citation records this snapshot. The page link may show a newer release later.	−USD 40.2 million Exact value Exact value: -40196000 USD 2023-01-01 – 2023-12-31: -40196000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Accelerate Diagnostics, Inc. · 2023-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Operating Cash Flow: -40196000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -40196000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828025014205/axdx-20241231.htm#1101307 Filing: 000162828025014205 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2024 2024-01-01 – 2024-12-31	−USD 50 million Exact value Exact value: -50000000 USD 2024-01-01 – 2024-12-31: -50000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Accelerate Diagnostics, Inc. · 2024-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Net Income: -50000000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -50000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828025014205/axdx-20241231.htm#1158925 Filing: 000162828025014205 The citation records this snapshot. The page link may show a newer release later.	−USD 24.2 million Exact value Exact value: -24200000 USD 2024-01-01 – 2024-12-31: -24200000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Accelerate Diagnostics, Inc. · 2024-12-31 Accelerate Diagnostics, Inc. (edgar:727207) Operating Cash Flow: -24200000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:03:33Z Snapshot: 9e0a5627d048e59f051851e6871968e74ee1b6e81f60943792cda5d1a75fdb6e Dimensions: Consolidated View: https://fundies.io/companies/edgar/727207/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24200000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/727207/000162828025014205/axdx-20241231.htm#1159119 Filing: 000162828025014205 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

280 filings · 4,284 latest values · 4,284 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000727207, 727207, AXDX, edgar:727207

Also known as ACCELERATE DIAGNOSTICS, INC., ACCELERATE DIAGNOSTICS, INC., ACCELR8 TECHNOLOGY CORP, Accelerate Diagnostics, Inc, Accelerate Diagnostics, Inc., Accelr8 Technology Corp, Accelr8 Technology Corp., Accelr8 Technology Corporation

Accelerate Diagnostics, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2024 2024-01-01 – 2024-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation